FDA Adverse Event Malfunction Summary report: N

ADVIA 120 HEMATOLOGY SYSTEM WITH AUTOSAMPLER

MDR report key: 11339896 · Received February 17, 2021

Report

Report Number
2432235-2021-00046
Event Type
Malfunction
Date Received
February 17, 2021
Date of Event
January 26, 2021
Report Date
March 19, 2021
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
GKZ
PMA / PMN Number
K971998
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

SIEMENS FILED THE INITIAL MDR 2432235-2021-00046 ON 17-FEB-2021. ADDITIONAL INFORMATION (02-MAR-2021): THE CUSTOMER WAS NOT WEARING THE RECOMMENDED PERSONAL PROTECTIVE EQUIPMENT AT THE TIME OF THE EVENT. AS PER THE ADVIA 120/2120/2120I HEMATOLOGY SYSTEM OPERATOR'S GUIDE: "ALL PRODUCTS OR OBJECTS THAT COME IN CONTACT WITH HUMAN OR ANIMAL BODY FLUIDS SHOULD BE HANDLED, BEFORE AND AFTER CLEANING, AS IF CAPABLE OF TRANSMITTING INFECTIOUS DISEASES. WEAR FACIAL PROTECTION, GLOVES, AND PROTECTIVE CLOTHING." THE CAUSE OF THE EVENT IS USE ERROR. THE SYSTEM IS PERFORMING ACCORDING TO SPECIFICATIONS. NO FURTHER EVALUATION OF THIS DEVICE IS REQUIRED.

Additional Manufacturer Narrative · 1

THE CUSTOMER CONTACTED A SIEMENS CUSTOMER CARE CENTER (CCC). SIEMENS IS INVESTIGATING THE ISSUE.

Description of Event or Problem · 1

WHILE REPLACING REAGENTS ON THE LABORATORY'S ADVIA 120 HEMATOLOGY SYSTEM, DROPS OF ADVIA 120/2120/2120I DIFF TIMEPAC REAGENT SPLASHED INTO THE CUSTOMER'S EYE, CAUSING IRRITATION. THE CUSTOMER WAS NOT WEARING EYE PROTECTION AT THE TIME OF THE EVENT. THE CUSTOMER WASHED HER EYE WITH WATER FOR 10 MINUTES, AND WAS PRESCRIBED EYE DROPS BY HER OPHTHALMOLOGIST. THERE ARE NO REPORTS OF ADVERSE HEALTH CONSEQUENCES DUE TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
234174 ADVIA 120 HEMATOLOGY SYSTEM WITH AUTOSAMPLER ADVIA 120 HEMATOLOGY SYSTEM WITH AUTOSAMPLER GKZ SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA 120 HEMATOLOGY SYSTEM WITH AUTOSAMPLER

Patients

Seq Age Sex Outcome Treatment
1